… , or 150 mg of dabigatran were classified as standard-dose … , we assumed that apixaban and
dabigatran were prescribed … , differential bleeding risks between rivaroxaban and apixaban …

… perception of increased bleeding risk in these patients. In daily … is adjusted in patients on
dabigatran or rivaroxaban, the full … infarction were on the low dose of apixaban, although they …

… with 15 and 20 mg/d (standard-dose) rivaroxaban in an Asian AF population, and … that the
risk of infarction was higher for low-dose rivaroxaban, while the risks of embolism and bleeding …

… that compared with warfarin, low-dose apixaban was associated with a lower … warfarin,
low-dose dabigatran was associated with a lower risk of major bleeding and a comparable risk of …

… that Apixaban was associated with lower risk of major and GI … bleeding, we found a similar
performance of Dabigatran with … number of events according to high and low dose of DOACs. …

… risk of stroke/systemic embolism (S/SE) and major bleeding (… (OACs; apixaban, dabigatran,
rivaroxaban, and warfarin) … reduced-dose apixaban, dabigatran, rivaroxaban, and warfarin, …

… mg of dabigatran twice daily, it was registered under the “Low-dose” … Apixaban is associated
with reduced GIH risk compared with Dabigatran, Rivaroxaban and VKA, that Dabigatran …

… , or major gastrointestinal bleeding events with the low dose. The authors suggest a role for
… for dabigatran, rivaroxaban, apixaban, and edoxaban based on risk factors such as age, …

… in this study were influenced by the inclusion of apixaban, dabigatran, … Comparative validation
of a novel risk score for predicting bleeding risk in … Other doses are considered low dose. …

… the combination of low-dose rivaroxaban and aspirin was … bleeding risk between apixaban
and VKAs in RENAL-AF. In our study, the risk of minor bleeding and gastrointestinal bleeding …